Increase/Decrease in Cash: The total change in cash for the company over the given period.
CG Oncology, Inc. (CGON) had Increase/Decrease in Cash of $248.80M for the most recently reported fiscal year, ending 2024-12-31.
| Income Statement Financials | |
$1.14M |
|
$-88.04M |
|
-- |
|
$1.14M |
|
$115.81M |
|
$-114.67M |
|
$26.63M |
|
$-88.04M |
|
$-88.04M |
|
$-88.04M |
|
$-88.04M |
|
$-88.04M |
|
$-88.04M |
|
$-114.67M |
|
$-119.63M |
|
62.50M |
|
62.50M |
|
$-1.41 |
|
$-1.41 |
|
| Balance Sheet Financials | |
$754.21M |
|
$0.27M |
|
$0.59M |
|
$754.80M |
|
$21.37M |
|
-- |
|
$0.05M |
|
$21.42M |
|
$733.38M |
|
$733.38M |
|
$733.38M |
|
76.16M |
|
| Cash Flow Statement Financials | |
$-78.71M |
|
$-300.76M |
|
$628.28M |
|
$8.27M |
|
$257.07M |
|
|
Increase/Decrease in Cash |
$248.80M |
$11.40M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
35.30 |
|
-- |
|
-- |
|
-- |
|
-- |
|
100.00% |
|
-10067.25% |
|
-10067.25% |
|
-10502.72% |
|
-7729.50% |
|
-7729.50% |
|
$-78.95M |
|
-- |
|
-- |
|
-- |
|
0.00 |
|
-- |
|
1.46 |
|
250.28 |
|
-12.00% |
|
-12.00% |
|
-11.66% |
|
-12.00% |
|
$9.63 |
|
$-1.26 |
|
$-1.26 |
|